Letter

Aspirin and cognitive decline

Too little, too late?

BMJ 2007; 334 doi: 10.1136/bmj.39220.421262.3A (Published 24 May 2007)
Cite this as: BMJ 2007;334:1071.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Richard J Prettyman, consultant old age psychiatrist
  1. Bennion Centre, Leicester LE3 9DZ
  1. richard.prettyman{at}leicspart.nhs.uk

    The study reported by Kang et al adds to the continuing debate about the usefulness (or lack thereof) of aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) in preventing and treating cognitive decline in later life.1 The …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular